Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA, 5S ribosomal pseudogene 110 (RNA5SP110) is a **pseudogene** in the human genome. Pseudogenes are typically segments of DNA that resemble known genes but are non-functional due to various disabling mutations or truncations. Unlike functional 5S ribosomal RNAs (5S rRNAs), which are integral to ribosome structure and protein synthesis[1][5], this pseudogene does not produce a functional RNA molecule. There is no evidence it serves as a therapeutic target, plays a direct role in disease, or interacts with drugs. It can be used for evolutionary or phylogenetic studies but has no known physiological or pharmacological function in humans[2][4][6]. Key points and clarification: - RNA5SP110 is explicitly classified as a **pseudogene**, not an active gene, protein, or receptor[2]. - It is **not a drug target**, not a receptor, enzyme, transporter, or transcription factor, and no biological function is known for this locus as a pseudogene[2][4][6]. - Pseudogenes may sometimes play roles through RNA interference or as competitive endogenous RNAs, but there is no evidence for such functions for RNA5SP110 specifically[4]. - If this entry appears in a therapeutic target list, it is inappropriate: it is **not a valid or meaningful drug target** and is thus marked as **is_incorrect: true**. - The closest actual biological entity is "5S ribosomal RNA," a structural RNA of the ribosome, but RNA5SP110 is not a functional copy—thus, no molecular classification like "receptor" or "enzyme" is appropriate[1][2][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, 5S ribosomal pseudogene 110 (RNA5SP110).